The best Bull and Bear pitches based on recency and number of recommendations.
When these inevitable broad declines come along, I start looking for two kinds of stocks: companies with potential that have been overly punished, and companies which are doomed long-term and haven't been punished enough. I try and green thumb the… More
Short. Biopharma. $0 Revenues. Consistent share dilution.
Read the most recent pitches from players about ALIM.
Recs
DeathStock
(97.70)
Submitted: 4/24/2016 6:32:43 PM :
Start Price:
$2.33
ALIM Score:
-93.37
http://caps.fool.com/Blogs/alimera-sciences-is-it-time/1074521
Recs
zzlangerhans
(99.55)
Submitted: 1/11/2016 8:49:40 AM :
Start Price:
$2.51
ALIM Score:
-103.72
When these inevitable broad declines come along, I start looking for two kinds of stocks: companies with potential that have been overly punished, and companies which are doomed long-term and haven't been punished enough. I try and green thumb the former and red thumb the latter. I've been an Alimera bear for quite some time, but the stock has now been beaten down enough that I'll hazard an outperform rating ahead of a predicted ramp in Iluvien sales in 2016 once a J code has been granted. I wouldn't use real money to bet that Alimera can achieve positive cash flow from Iluvien based on their optimistic projections, but I'll risk an accuracy point to follow the story in the virtual realm.
Recs
rknapton
(57.09)
Submitted: 7/23/2013 8:12:18 PM :
Start Price:
$5.10
ALIM Score:
+144.56
Short. Biopharma. $0 Revenues. Consistent share dilution.
Find the members with the highest scoring picks in ALIM.
htsigns (< 20) Score: +230.69
The Score Leader is the player with the highest score across all their picks in ALIM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Halffrenzy | 25.33 | 7/5/2013 |
|
5Y | $4.95 | -82.22% | +69.10% | +151.33 | 0 Comment | |
| rknapton | 57.09 | 7/24/2013 |
|
5Y | $5.10 | -82.75% | +61.81% | +144.56 | 1 Comment | |
| KidJones | 30.06 | 2/14/2013 |
|
5Y | $2.36 | -62.72% | +81.12% | +143.84 | 0 Comment | |
| IdahoInvestor | 30.09 | 1/18/2012 |
|
5Y | $1.20 | -26.68% | +111.11% | +137.79 | 0 Comment | |
| pro64grammer | 28.82 | 12/19/2013 |
|
5Y | $4.46 | -80.27% | +51.58% | +131.85 | 0 Comment | |
| ultrasounddoc | < 20 | 5/9/2014 |
|
5Y | $5.42 | -83.77% | +46.38% | +130.15 | 0 Comment | |
| mikefee | 91.01 | 6/26/2014 |
|
5Y | $6.01 | -85.36% | +40.45% | +125.81 | 0 Comment | |
| SimonSaysSell | 97.47 | 10/31/2013 |
|
NS | $2.14 | -58.88% | +55.97% | +114.85 | 0 Comment | |
| Imhilion | 29.73 | 12/2/2013 |
|
1Y | $2.36 | -62.69% | +51.79% | +114.48 | 0 Comment | |
| barcharttracker1 | < 20 | 3/4/2016 |
|
NS | $1.82 | -51.65% | +37.36% | +89.02 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackJimCramer | 85.44 | 3/28/2014 |
|
3W | $7.20 | -87.78% | +48.12% | +135.89 | 0 Comment | |
| TrackBWS | 96.73 | 11/11/2011 |
|
NS | $1.84 | -33.70% | -5.20% | +28.49 | 11/28/2011 @ $1.22 | 0 Comment |
| TrackOppenheimer | 76.02 | 12/27/2010 |
|
NS | $9.00 | -90.22% | +119.56% | -209.79 | 0 Comment | |
| TrackRodmanRen | < 20 | 10/11/2010 |
|
NS | $10.99 | -84.26% | +7.27% | -91.52 | 11/14/2011 @ $1.73 | 0 Comment |
